CPI-0610 Shows Clinical Activity in Patients With Myelofibrosis Targeted Oncology 1:53 4 years ago 83 Далее Скачать
Dr. Kremyanskaya on Responses With CPI-0610 in Patients With Myelofibrosis OncLive 1:08 4 years ago 113 Далее Скачать
Dr. Kremyanskaya on Effect of CPI-0610 in Patients With Myelofibrosis OncLive 1:00 4 years ago 90 Далее Скачать
MANIFEST: pelabresib (CPI-0610) shows promise in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:33 3 years ago 144 Далее Скачать
JAKARTA-2 Reanalysis Demonstrates Activity With Fedratinib in MF After Ruxolitinib Failure Targeted Oncology 1:54 5 years ago 324 Далее Скачать
MANIFEST: pelabresib (CPI-0610) + ruxolitinib in advanced myelofibrosis patients VJHemOnc – Video Journal of Hematology & HemOnc 3:49 4 years ago 314 Далее Скачать
BET Inhibitor pelabresib (CPI-0610) and ruxolitinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:27 5 years ago 397 Далее Скачать
Pelabresib (CPI-0610): a novel BET inhibitor for MF VJHemOnc – Video Journal of Hematology & HemOnc 2:08 4 years ago 376 Далее Скачать
Dr. Verstovsek on the MANIFEST Trial With CPI-0610 in Myelofibrosis OncLive 1:45 4 years ago 87 Далее Скачать
Dr. Kremyanskaya on MANIFEST Trial With CPI-0610 in Myelofibrosis OncLive 1:44 4 years ago 55 Далее Скачать
MANIFEST study: Does the BET inhibitor CPI-0610 show synergy with ruxolitinib in MF? MPN Hub 3:38 4 years ago 180 Далее Скачать
MANIFEST study of pelabresib (CPI-0610) in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:06 5 years ago 598 Далее Скачать
Evaluating CPI-0610 as Treatment of Patients With Myelofibrosis Targeted Oncology 1:45 4 years ago 70 Далее Скачать
MANIFEST study: Does the BET inhibitor CPI-0610 show synergy with ruxolitinib in myelofibrosis? MPN Hub 3:57 3 years ago 68 Далее Скачать
Novel therapies for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:41 4 years ago 275 Далее Скачать
Improved survival of myelofibrosis patients receiving ruxolitinib post allo-HSCT VJHemOnc – Video Journal of Hematology & HemOnc 2:14 3 years ago 308 Далее Скачать
Evaluating Prognosis and Treatment Options for Patients With Myelofibrosis Targeted Oncology 2:03 5 years ago 146 Далее Скачать
Phase I study of ruxolitinib plus abemaciclib for patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:01 1 year ago 124 Далее Скачать
Fedratinib Reemerges as FDA-Approved Treatment of Myelofibrosis Targeted Oncology 1:10 5 years ago 387 Далее Скачать
